Details of the Drug Combinations

General Information of This Drug (ID: DMXYJ9C)

Drug Name

Busulfan DMXYJ9C

Synonyms

Busulfano; Busulfanum; Busulfex; Busulphan; Busulphane; Butanedioldimethanesulfonate; Buzulfan; Citosulfan; Glyzophrol; Leucosulfan; Mablin; Methanesulfonic; Mielevcin; Mielosan; Mielucin; Milecitan; Mileran; Misulban; Mitosan; Mitostan; Myeleukon; Myeloleukon; Myelosan; Myelosanum; Mylecytan; Myleran; Mylerlan; Sulfabutin; Sulphabutin; Busulfan GlaxoSmithKline Brand; Busulfan Orphan Brand; Busulfan Wellcome; Busulfan Wellcome Brand; Glaxo Wellcome Brand of Busulfan; GlaxoSmithKline Brand of Busulfan; Myleran tablets; Orphan Brand of Busulfan; Tetramethylene bis[methanesulfonate]; Tetramethylene dimethane sulfonate; Tetramethylenester kyseliny methansulfonove; Tetramethylenester kyseliny methansulfonove[Czech]; Wellcome Brand of Busulfan; AN 33501; CB 2041; GT 2041; GT 41; X 149; Acid, tetramethylene ester; Alkylating agent: crosslinks guanine residues; Busulfan [INN:JAN]; Busulfano [INN-Spanish]; Busulfanum [INN-Latin]; MYLERAN (TN); Methanesulfonic acid, tetram ethylene ester; Methanesulfonic acid, tetramethylene ester; Myleran (TN); Sulfabutin (VAN); Tetramethylene bis(methanesulfonate); Tetramethylene {bis[methanesulfonate]}; Wellcome, Busulfan; C.B. 2041; G.T. 41; Myleran, Busulfex, Busulfan; Busulfan (JP15/USP/INN); Butane-1,4-diyl dimethanesulfonate; BUSULFAN (1,4-BUTANEDIOL, DIMETHANESULFONATE); N-Butane-1,3-di(methylsulfonate); 1,4-BUTANEDIOL DIMETHANESULFONATE; 1,4-Bis(methanesulfonoxy)butane; 1,4-Bis(methanesulfonyloxy)butane; 1,4-Bis[methanesulfonoxy]butane; 1,4-Butanedi yl dimethanesulfonate; 1,4-Butanediol dimethanesulphonate; 1,4-Butanediol dimethylsulfonate; 1,4-Butanediol, dimethanesulfonate; 1,4-Butanediol, dimethanesulphonate; 1,4-Butanediyl dimethanesulfonate; 1,4-Di(methylsulfonoxy)butane; 1,4-Dimesyloxybutane; 1,4-Dimethane sulfonyl oxybutane; 1,4-Dimethanesulfonoxybutane; 1,4-Dimethanesulfonoxylbutane; 1,4-Dimethanesulfonyloxybutane; 1,4-Dimethanesulphonyloxybutane; 1,4-Dimethylsulfonoxybutane; 1,4-Dimethylsulfonyloxybutane; 1,{4-Bis[methanesulfonoxy]butane}; 4-((Methylsulfonyl)oxy)butyl methanesulfonate; 4-methylsulfonyloxybutyl methanesulfonate

Indication

Disease Entry	ICD 11	Status	REF
Chronic myelogenous leukaemia	2A20.0	Approved	[1]
Hematologic disease	3C0Z	Approved	[1]
Immunodeficiency	4A00-4A85	Approved	[1]
Leukemia	N.A.	Approved	[1]
Myeloproliferative syndrome	2A22	Approved	[2]
Systemic lupus erythematosus	4A40.0	Approved	[1]
Systemic sclerosis	4A42	Approved	[1]
Neuroblastoma	2D11.2	Investigative	[1]
Retinoblastoma	2D02.2	Investigative	[1]
------------------------------------------------------------------------------------


⏷ Show the Full List of Indication(s)

Therapeutic Class

Anticancer Agents

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

383 Investigative Drug Combination(s) Consisting of This drug

Normalized Drug Combination Synergy Score

Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
10-hydroxycamptothecin + Busulfan	DCQAWUZ	10-hydroxycamptothecin	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)	[3]
ABIRATERONE + Busulfan	DCADIFJ	ABIRATERONE	Renal cell carcinoma (Cell Line: UO-31)	[4]
Acamprosate + Busulfan	DCHFWPX	Acamprosate	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Aminolevulinic Acid Hydrochloride + Busulfan	DC3T23Z	Aminolevulinic Acid Hydrochloride	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[4]
Aminolevulinic Acid Hydrochloride + Busulfan	DC7HH8E	Aminolevulinic Acid Hydrochloride	Anaplastic large cell lymphoma (Cell Line: SR)	[4]
Amodiaquine + Busulfan	DC1NKOK	Amodiaquine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Amonafide + Busulfan	DCM75HL	Amonafide	Adenocarcinoma (Cell Line: NCIH23)	[4]
Amonafide + Busulfan	DCI3K9B	Amonafide	Adenocarcinoma (Cell Line: SW-620)	[4]
Amonafide + Busulfan	DCAJTA9	Amonafide	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[4]
Amonafide + Busulfan	DCEBNQD	Amonafide	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[4]
Amonafide + Busulfan	DC53V0C	Amonafide	Anaplastic large cell lymphoma (Cell Line: SR)	[4]
Amonafide + Busulfan	DCVCL3V	Amonafide	Astrocytoma (Cell Line: U251)	[4]
Amonafide + Busulfan	DCQ5NWB	Amonafide	Chronic myelogenous leukemia (Cell Line: K-562)	[4]
Amonafide + Busulfan	DCZT9S8	Amonafide	Glioma (Cell Line: SF-268)	[4]
Amonafide + Busulfan	DCNQ0L0	Amonafide	Glioma (Cell Line: SF-539)	[4]
Amonafide + Busulfan	DCJAVRL	Amonafide	Plasma cell myeloma (Cell Line: RPMI-8226)	[4]
Amonafide + Busulfan	DCH4LXP	Amonafide	Colon adenocarcinoma (Cell Line: COLO 205)	[5]
Anastrozole + Busulfan	DC3IK7W	Anastrozole	Adenocarcinoma (Cell Line: HT29)	[4]
Anastrozole + Busulfan	DCDMPBB	Anastrozole	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[4]
Anastrozole + Busulfan	DCHW3E5	Anastrozole	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[4]
Anastrozole + Busulfan	DC7XZ3A	Anastrozole	Chronic myelogenous leukemia (Cell Line: K-562)	[4]
Anastrozole + Busulfan	DC5ZSWM	Anastrozole	Clear cell renal cell carcinoma (Cell Line: A498)	[4]
Anastrozole + Busulfan	DC4RHSZ	Anastrozole	Cutaneous melanoma (Cell Line: SK-MEL-5)	[4]
Anastrozole + Busulfan	DCVGKR5	Anastrozole	Glioma (Cell Line: SF-539)	[4]
Anastrozole + Busulfan	DCXN383	Anastrozole	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)	[4]
Anastrozole + Busulfan	DCOS7TZ	Anastrozole	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[4]
Anastrozole + Busulfan	DCV0OB8	Anastrozole	Plasma cell myeloma (Cell Line: RPMI-8226)	[4]
Anastrozole + Busulfan	DCG3WI5	Anastrozole	Colon adenocarcinoma (Cell Line: COLO 205)	[5]
Arfolitixorin + Busulfan	DCRBXKR	Arfolitixorin	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Atovaquone + Busulfan	DCXU0R3	Atovaquone	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Auranofin + Busulfan	DCGQN7D	Auranofin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Azacitidine + Busulfan	DCHMLIW	Azacitidine	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[4]
Azacitidine + Busulfan	DCBTNRT	Azacitidine	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[5]
BIO-300 + Busulfan	DCODSHF	BIO-300	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[4]
BIO-300 + Busulfan	DCJS0XJ	BIO-300	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
BIO-300 + Busulfan	DCCCI8P	BIO-300	Chronic myelogenous leukemia (Cell Line: K-562)	[4]
BIO-300 + Busulfan	DC0M0DU	BIO-300	Glioma (Cell Line: SF-268)	[4]
BIO-300 + Busulfan	DC8ZZ0R	BIO-300	Renal cell carcinoma (Cell Line: SN12C)	[4]
BIO-300 + Busulfan	DCU4095	BIO-300	Colon adenocarcinoma (Cell Line: COLO 205)	[5]
BIO-300 + Busulfan	DCPUSEZ	BIO-300	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)	[3]
Bleomycin + Busulfan	DCG8MX3	Bleomycin	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[4]
Bleomycin + Busulfan	DCNV7MJ	Bleomycin	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[4]
Bleomycin + Busulfan	DCB8ZXY	Bleomycin	Anaplastic large cell lymphoma (Cell Line: SR)	[4]
Bleomycin + Busulfan	DCF0SNB	Bleomycin	Chronic myelogenous leukemia (Cell Line: K-562)	[4]
Bleomycin + Busulfan	DCML76U	Bleomycin	Glioma (Cell Line: SF-539)	[4]
Bleomycin + Busulfan	DCRIJ1K	Bleomycin	Plasma cell myeloma (Cell Line: RPMI-8226)	[4]
Bleomycin + Busulfan	DCKJNFK	Bleomycin	Colon adenocarcinoma (Cell Line: COLO 205)	[5]
Bleomycin + Busulfan	DC6MYBF	Bleomycin	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)	[3]
Bortezomib + Busulfan	DC6L5B4	Bortezomib	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Busulfan + Pentostatin	DCNHN2U	Pentostatin	Adenocarcinoma (Cell Line: HCT116)	[4]
Busulfan + Pentostatin	DCTJCZ3	Pentostatin	Glioblastoma (Cell Line: SNB-75)	[4]
Busulfan + Pentostatin	DCSG3GC	Pentostatin	Glioma (Cell Line: SF-539)	[4]
Busulfan + Aliskiren	DCISUEU	Aliskiren	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Busulfan + Dantrolene	DCAHW6K	Dantrolene	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Busulfan + Diethylcarbamazine	DCWKRO1	Diethylcarbamazine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Busulfan + Epinephrine	DC9QZ5N	Epinephrine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Busulfan + PMID28460551-Compound-2	DCCWFIW	PMID28460551-Compound-2	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Busulfan + Cyclophosphamide	DCTQWWZ	Cyclophosphamide	Adenocarcinoma (Cell Line: HCC-2998)	[4]
Busulfan + Cyclophosphamide	DC8B7U9	Cyclophosphamide	Adenocarcinoma (Cell Line: HT29)	[4]
Busulfan + Isoniazid	DCR7R33	Isoniazid	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[4]
Busulfan + Arsenic trioxide	DCLLOT2	Arsenic trioxide	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[4]
Busulfan + Arsenic trioxide	DC03LMF	Arsenic trioxide	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)	[4]
Busulfan + Arsenic trioxide	DCOMBER	Arsenic trioxide	Large cell lung carcinoma (Cell Line: NCI-H460)	[4]
Busulfan + Arsenic trioxide	DCITNW0	Arsenic trioxide	Malignant melanoma (Cell Line: LOX IMVI)	[4]
Busulfan + Anamorelin	DCJ3Q58	Anamorelin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Busulfan + Triapine	DC28H1P	Triapine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Busulfan + Topetecan	DC1GFS5	Topetecan	Adenocarcinoma (Cell Line: HCT116)	[4]
Busulfan + Topetecan	DCALDAT	Topetecan	Anaplastic large cell lymphoma (Cell Line: SR)	[4]
Busulfan + IT-141	DC2LZFT	IT-141	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Busulfan + Metyrosine	DC9KGFL	Metyrosine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Busulfan + Ifosfamide	DCJ7PAJ	Ifosfamide	Adenocarcinoma (Cell Line: NCIH23)	[4]
Busulfan + Ifosfamide	DCK2VNA	Ifosfamide	Adenocarcinoma (Cell Line: HCC-2998)	[4]
Busulfan + Ifosfamide	DCU56O9	Ifosfamide	Chronic myelogenous leukemia (Cell Line: K-562)	[4]
Busulfan + Ifosfamide	DCX1U5N	Ifosfamide	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)	[4]
Busulfan + Doxapram	DCEKLM8	Doxapram	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Busulfan + Chlorzoxazone	DCWTPTF	Chlorzoxazone	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Busulfan + Memantine	DCICI5R	Memantine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Busulfan + Pazopanib	DCWLDIE	Pazopanib	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Busulfan + Bendamustine hydrochloride	DC4C8NM	Bendamustine hydrochloride	Adenocarcinoma (Cell Line: HCT116)	[4]
Busulfan + Bendamustine hydrochloride	DCIKJ4R	Bendamustine hydrochloride	Plasma cell myeloma (Cell Line: RPMI-8226)	[4]
Busulfan + Mecamylamine	DC372FA	Mecamylamine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Busulfan + Mitomycin	DC98WOL	Mitomycin	Adenocarcinoma (Cell Line: DU-145)	[4]
Busulfan + Mitomycin	DCIV84Z	Mitomycin	Adenocarcinoma (Cell Line: HT29)	[4]
Busulfan + Mitomycin	DCX6UT2	Mitomycin	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[4]
Busulfan + Mitomycin	DCXXTI4	Mitomycin	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[4]
Busulfan + Mitomycin	DC3XOYD	Mitomycin	Lung adenocarcinoma (Cell Line: NCI-H522)	[4]
Busulfan + Mitomycin	DCWXCL6	Mitomycin	Plasma cell myeloma (Cell Line: RPMI-8226)	[4]
Busulfan + Altretamine	DCVA5OQ	Altretamine	Adenocarcinoma (Cell Line: DU-145)	[4]
Busulfan + Altretamine	DCPAAV4	Altretamine	Adenocarcinoma (Cell Line: SW-620)	[4]
Busulfan + Altretamine	DCYTYP2	Altretamine	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[4]
Busulfan + Altretamine	DCHLKLA	Altretamine	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[4]
Busulfan + Altretamine	DCKU688	Altretamine	Cutaneous melanoma (Cell Line: SK-MEL-5)	[4]
Busulfan + Altretamine	DCD0SJ8	Altretamine	Cutaneous melanoma (Cell Line: SK-MEL-28)	[4]
Busulfan + Altretamine	DCYLPI8	Altretamine	Glioma (Cell Line: SF-295)	[4]
Busulfan + Altretamine	DC7I0VE	Altretamine	Lung adenocarcinoma (Cell Line: HOP-62)	[4]
Busulfan + Altretamine	DCEFUGI	Altretamine	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[4]
Busulfan + Altretamine	DCHTONJ	Altretamine	Renal cell carcinoma (Cell Line: SN12C)	[4]
Busulfan + Diazoxide	DC3RCDZ	Diazoxide	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Busulfan + Idarubicin	DCJBRB5	Idarubicin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Busulfan + Idarubicin	DCNN559	Idarubicin	Glioblastoma? (Cell Line: T98G)	[4]
Busulfan + Probenecid	DC0OE6Q	Probenecid	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Busulfan + Methylene blue	DCHHJT6	Methylene blue	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Busulfan + Maprotiline	DCISWG2	Maprotiline	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Busulfan + Oxyphenbutazone	DCNSD1X	Oxyphenbutazone	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Busulfan + Leflunomide	DCD4PSW	Leflunomide	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Busulfan + Cisplatin	DCO26WC	Cisplatin	Adenocarcinoma (Cell Line: DU-145)	[4]
Busulfan + Cisplatin	DC4YCWB	Cisplatin	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[4]
Busulfan + Cisplatin	DCW3NTJ	Cisplatin	Large cell lung carcinoma (Cell Line: NCI-H460)	[4]
Busulfan + Chlorambucil	DC4Y07M	Chlorambucil	Adenocarcinoma (Cell Line: NCIH23)	[4]
Busulfan + Chlorambucil	DCP6BV9	Chlorambucil	Adenocarcinoma (Cell Line: HCC-2998)	[4]
Busulfan + Chlorambucil	DCODFUU	Chlorambucil	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[4]
Busulfan + Chlorambucil	DCKSVR1	Chlorambucil	Clear cell renal cell carcinoma (Cell Line: A498)	[4]
Busulfan + Chlorambucil	DCJYGH2	Chlorambucil	Clear cell renal cell carcinoma (Cell Line: 786-0)	[4]
Busulfan + Chlorambucil	DCWZ632	Chlorambucil	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)	[4]
Busulfan + Chlorambucil	DCA832U	Chlorambucil	Lung adenocarcinoma (Cell Line: EKVX)	[4]
Busulfan + Amantadine	DC89QEN	Amantadine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Busulfan + ER819762	DCCM2LH	ER819762	Clear cell renal cell carcinoma (Cell Line: A498)	[4]
Busulfan + ER819762	DC2RLDI	ER819762	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[4]
Busulfan + ER819762	DC9PZV0	ER819762	Lung adenocarcinoma (Cell Line: EKVX)	[4]
Busulfan + ER819762	DCBJOH9	ER819762	Renal cell carcinoma (Cell Line: UO-31)	[4]
Busulfan + Pomalidomide	DCO6NKP	Pomalidomide	Adenocarcinoma (Cell Line: OVCAR3)	[4]
Busulfan + Pomalidomide	DCKEVOK	Pomalidomide	Adenocarcinoma (Cell Line: SW-620)	[4]
Busulfan + Pomalidomide	DCXQD2K	Pomalidomide	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[4]
Busulfan + Pomalidomide	DCRJS6O	Pomalidomide	Anaplastic large cell lymphoma (Cell Line: SR)	[4]
Busulfan + Pomalidomide	DC5KH3F	Pomalidomide	Chronic myelogenous leukemia (Cell Line: K-562)	[4]
Busulfan + Pomalidomide	DCAOGIH	Pomalidomide	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)	[4]
Busulfan + Pomalidomide	DC5I2KP	Pomalidomide	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[4]
Busulfan + Pomalidomide	DCZUTFP	Pomalidomide	Melanoma (Cell Line: MALME-3M)	[4]
Busulfan + Spironolactone	DCVFDIL	Spironolactone	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Busulfan + Mycophenolic acid	DCQNA5W	Mycophenolic acid	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Busulfan + Doxorubicin	DCK47OA	Doxorubicin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Busulfan + PMID28870136-Compound-43	DCFLJY2	PMID28870136-Compound-43	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[4]
Busulfan + PMID28870136-Compound-43	DC9KYGS	PMID28870136-Compound-43	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[4]
Busulfan + FORMESTANE	DCAKJE8	FORMESTANE	Adenocarcinoma (Cell Line: OVCAR3)	[4]
Busulfan + FORMESTANE	DCKU2XL	FORMESTANE	Adenocarcinoma (Cell Line: NCIH23)	[4]
Busulfan + FORMESTANE	DCA5UUM	FORMESTANE	Adenocarcinoma (Cell Line: HCT116)	[4]
Busulfan + FORMESTANE	DCPZWMS	FORMESTANE	Adenocarcinoma (Cell Line: SW-620)	[4]
Busulfan + FORMESTANE	DCV2S7Q	FORMESTANE	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[4]
Busulfan + FORMESTANE	DC53DMC	FORMESTANE	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[4]
Busulfan + FORMESTANE	DCG9EBX	FORMESTANE	Amelanotic melanoma (Cell Line: M14)	[4]
Busulfan + FORMESTANE	DC5BTNT	FORMESTANE	Astrocytoma (Cell Line: SNB-19)	[4]
Busulfan + FORMESTANE	DCIFTSN	FORMESTANE	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[4]
Busulfan + FORMESTANE	DCL9ESH	FORMESTANE	Chronic myelogenous leukemia (Cell Line: K-562)	[4]
Busulfan + FORMESTANE	DC1ONGM	FORMESTANE	Clear cell renal cell carcinoma (Cell Line: TK-10)	[4]
Busulfan + FORMESTANE	DCTBO2K	FORMESTANE	Cutaneous melanoma (Cell Line: SK-MEL-28)	[4]
Busulfan + FORMESTANE	DCWSZ9N	FORMESTANE	Cutaneous melanoma (Cell Line: SK-MEL-5)	[4]
Busulfan + FORMESTANE	DC9DVP6	FORMESTANE	Glioma (Cell Line: SF-539)	[4]
Busulfan + FORMESTANE	DCG6N37	FORMESTANE	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[4]
Busulfan + FORMESTANE	DC304KY	FORMESTANE	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[4]
Busulfan + FORMESTANE	DCU6VSB	FORMESTANE	Lung adenocarcinoma (Cell Line: HOP-62)	[4]
Busulfan + FORMESTANE	DCPI0H0	FORMESTANE	Melanoma (Cell Line: SK-MEL-2)	[4]
Busulfan + FORMESTANE	DCOGRNR	FORMESTANE	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[4]
Busulfan + FORMESTANE	DCQGM53	FORMESTANE	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[4]
Busulfan + Vorinostat	DCQQI17	Vorinostat	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Busulfan + Acetohydroxamic Acid	DCGJN2Q	Acetohydroxamic Acid	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Busulfan + GSK2194069	DC4IA36	GSK2194069	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Busulfan + Cilostazol	DCBRJO0	Cilostazol	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Busulfan + Pentostatin	DCTKFO6	Pentostatin	Colon adenocarcinoma (Cell Line: COLO 205)	[5]
Busulfan + Pentostatin	DCXFPLJ	Pentostatin	Colon carcinoma (Cell Line: KM12)	[5]
Busulfan + Isoniazid	DCC7CE9	Isoniazid	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[5]
Busulfan + Altretamine	DC5THFC	Altretamine	Carcinoma (Cell Line: RXF 393)	[5]
Busulfan + Pomalidomide	DCCI5KT	Pomalidomide	Carcinoma (Cell Line: RXF 393)	[5]
Cerivastatin + Busulfan	DCMTK4O	Cerivastatin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Cisatracurium + Busulfan	DCUA16V	Cisatracurium	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Dacarbazine + Busulfan	DCVB4NL	Dacarbazine	Glioma (Cell Line: SF-539)	[4]
Dacarbazine + Busulfan	DCF9IX2	Dacarbazine	Glioma (Cell Line: SF-268)	[4]
Dacarbazine + Busulfan	DCIVUPG	Dacarbazine	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[4]
Dactinomycin + Busulfan	DC8PVM1	Dactinomycin	Anaplastic large cell lymphoma (Cell Line: SR)	[3]
Dactinomycin + Busulfan	DCRWO02	Dactinomycin	Lung adenocarcinoma (Cell Line: HOP-62)	[3]
Dactinomycin + Busulfan	DCJF5C7	Dactinomycin	Lung adenocarcinoma (Cell Line: NCI-H522)	[3]
Dactinomycin + Busulfan	DCUZU8E	Dactinomycin	Malignant melanoma (Cell Line: LOX IMVI)	[3]
Dasatinib + Busulfan	DCH62LX	Dasatinib	Adenocarcinoma (Cell Line: NCIH23)	[4]
Dasatinib + Busulfan	DCHDRXI	Dasatinib	Adenocarcinoma (Cell Line: HCT116)	[4]
Dasatinib + Busulfan	DCQQQKM	Dasatinib	Amelanotic melanoma (Cell Line: MDA-MB-435)	[4]
Dexrazoxane + Busulfan	DCEJ2T4	Dexrazoxane	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[4]
Dexrazoxane + Busulfan	DCZG2OX	Dexrazoxane	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[4]
Dexrazoxane + Busulfan	DCMYW3J	Dexrazoxane	Anaplastic large cell lymphoma (Cell Line: SR)	[4]
Dexrazoxane + Busulfan	DCVWZSG	Dexrazoxane	Glioma (Cell Line: SF-268)	[4]
Dexrazoxane + Busulfan	DCACPAN	Dexrazoxane	Colon adenocarcinoma (Cell Line: COLO 205)	[5]
Dexrazoxane + Busulfan	DCNASI5	Dexrazoxane	Invasive ductal carcinoma (Cell Line: BT-549)	[5]
Dexrazoxane + Busulfan	DC9T2KH	Dexrazoxane	Invasive ductal carcinoma (Cell Line: HS 578T)	[5]
Dexrazoxane + Busulfan	DCWQJUJ	Dexrazoxane	Adenocarcinoma (Cell Line: HCT116)	[3]
DFN-15 + Busulfan	DCVCLTG	DFN-15	Astrocytoma (Cell Line: SNB-19)	[4]
DFN-15 + Busulfan	DCEVM0C	DFN-15	Clear cell renal cell carcinoma (Cell Line: 786-0)	[4]
DFN-15 + Busulfan	DCQQP4U	DFN-15	Glioma (Cell Line: SF-539)	[4]
DFN-15 + Busulfan	DCWLOWE	DFN-15	Adenocarcinoma (Cell Line: DU-145)	[3]
DFN-15 + Busulfan	DCY5V6U	DFN-15	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[3]
Digitoxin + Busulfan	DCBF0YK	Digitoxin	Glioblastoma (Cell Line: SNB-75)	[4]
Docetaxel + Busulfan	DCO7GJI	Docetaxel	Adenocarcinoma (Cell Line: HCT116)	[4]
Docetaxel + Busulfan	DCESKZX	Docetaxel	Invasive ductal carcinoma (Cell Line: BT-549)	[5]
Emetine + Busulfan	DCZAOJ2	Emetine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Estramustine + Busulfan	DC672CD	Estramustine	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[3]
Etomidate + Busulfan	DC4M6CB	Etomidate	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Fludarabine + Busulfan	DCZQXKC	Fludarabine	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[4]
Fludarabine + Busulfan	DCB6X93	Fludarabine	Anaplastic large cell lymphoma (Cell Line: SR)	[4]
Fludarabine + Busulfan	DCVM8AY	Fludarabine	Carcinoma (Cell Line: MCF7)	[5]
Fomepizole + Busulfan	DCN8EBG	Fomepizole	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Fosfomycin + Busulfan	DCB7O9U	Fosfomycin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Fulvestrant + Busulfan	DCWUCSZ	Fulvestrant	Cutaneous melanoma (Cell Line: SK-MEL-28)	[4]
Fulvestrant + Busulfan	DCZ7W81	Fulvestrant	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[4]
Galantamine + Busulfan	DCMIZ7D	Galantamine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Gefitinib + Busulfan	DCZ0S12	Gefitinib	Adenocarcinoma (Cell Line: DU-145)	[4]
Gefitinib + Busulfan	DC57FWB	Gefitinib	Adenocarcinoma (Cell Line: SW-620)	[4]
Gefitinib + Busulfan	DCTYGHA	Gefitinib	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[4]
Gefitinib + Busulfan	DCDLXMH	Gefitinib	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[4]
Gefitinib + Busulfan	DCE1JG3	Gefitinib	Anaplastic large cell lymphoma (Cell Line: SR)	[4]
Gefitinib + Busulfan	DCUNAAH	Gefitinib	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[4]
Gefitinib + Busulfan	DCL223O	Gefitinib	Chronic myelogenous leukemia (Cell Line: K-562)	[4]
Gefitinib + Busulfan	DCWN64S	Gefitinib	Clear cell renal cell carcinoma (Cell Line: TK-10)	[4]
Gefitinib + Busulfan	DCSTLD3	Gefitinib	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[4]
Gefitinib + Busulfan	DCZMPAA	Gefitinib	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[4]
Gefitinib + Busulfan	DCFWSYF	Gefitinib	Renal cell carcinoma (Cell Line: SN12C)	[4]
Gefitinib + Busulfan	DCTNYCT	Gefitinib	Carcinoma (Cell Line: MCF7)	[5]
Gefitinib + Busulfan	DC7URS0	Gefitinib	Colon adenocarcinoma (Cell Line: COLO 205)	[5]
Gefitinib + Busulfan	DCRUPJM	Gefitinib	Colon carcinoma (Cell Line: KM12)	[5]
Gefitinib + Busulfan	DC5UX58	Gefitinib	Invasive ductal carcinoma (Cell Line: HS 578T)	[5]
Idarubicin + Busulfan	DC06YGM	Idarubicin	Adenocarcinoma (Cell Line: DU-145)	[3]
Idarubicin + Busulfan	DCJP8YU	Idarubicin	Adenocarcinoma (Cell Line: HCC-2998)	[3]
Imatinib + Busulfan	DCWHF4O	Imatinib	Adenocarcinoma (Cell Line: HCT-15)	[4]
Imatinib + Busulfan	DCJDBPT	Imatinib	Glioma (Cell Line: SF-268)	[4]
Imatinib + Busulfan	DCX15FU	Imatinib	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[4]
Indazole derivative 5 + Busulfan	DC2NOC9	Indazole derivative 5	Lung adenocarcinoma (Cell Line: HOP-62)	[3]
JNK-IN-8 + Busulfan	DCBHCJV	JNK-IN-8	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)	[3]
Kanamycin + Busulfan	DCPE6GA	Kanamycin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Lapatinib + Busulfan	DCDM9XR	Lapatinib	Cutaneous melanoma (Cell Line: SK-MEL-28)	[3]
Lapatinib + Busulfan	DCZP2KR	Lapatinib	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[3]
Lenalidomide + Busulfan	DCAM0AS	Lenalidomide	Chronic myelogenous leukemia (Cell Line: K-562)	[4]
Lenalidomide + Busulfan	DC93A1I	Lenalidomide	Plasma cell myeloma (Cell Line: RPMI-8226)	[4]
Lenalidomide + Busulfan	DCJOFPZ	Lenalidomide	Carcinoma (Cell Line: MCF7)	[5]
Lenalidomide + Busulfan	DCBD02A	Lenalidomide	Adenocarcinoma (Cell Line: HCT-15)	[3]
Lenalidomide + Busulfan	DCZPD7U	Lenalidomide	Adenocarcinoma (Cell Line: HT29)	[3]
Lenalidomide + Busulfan	DCZGAV2	Lenalidomide	Cutaneous melanoma (Cell Line: SK-MEL-28)	[3]
Lenalidomide + Busulfan	DC519YA	Lenalidomide	Cutaneous melanoma (Cell Line: SK-MEL-5)	[3]
Lenalidomide + Busulfan	DCDTC43	Lenalidomide	Lung adenocarcinoma (Cell Line: EKVX)	[3]
Lenalidomide + Busulfan	DCK8KQF	Lenalidomide	Melanoma (Cell Line: SK-MEL-2)	[3]
Lenalidomide + Busulfan	DC6KEWD	Lenalidomide	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[3]
Lenalidomide + Busulfan	DCMTAJ9	Lenalidomide	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Lenalidomide + Busulfan	DCNYXV0	Lenalidomide	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[3]
Letrozole + Busulfan	DCC7KQW	Letrozole	Adenocarcinoma (Cell Line: DU-145)	[4]
Letrozole + Busulfan	DC24Y5I	Letrozole	Adenocarcinoma (Cell Line: HCT-15)	[4]
Letrozole + Busulfan	DC24BHY	Letrozole	Amelanotic melanoma (Cell Line: MDA-MB-435)	[4]
Letrozole + Busulfan	DCTPM83	Letrozole	Anaplastic large cell lymphoma (Cell Line: SR)	[4]
Letrozole + Busulfan	DCPBH9K	Letrozole	Astrocytoma (Cell Line: U251)	[4]
Letrozole + Busulfan	DCPHO3Y	Letrozole	Clear cell renal cell carcinoma (Cell Line: 786-0)	[4]
Letrozole + Busulfan	DCHDR52	Letrozole	Glioblastoma (Cell Line: SNB-75)	[4]
Letrozole + Busulfan	DC3OQXC	Letrozole	Glioma (Cell Line: SF-268)	[4]
Letrozole + Busulfan	DCX9F86	Letrozole	Large cell lung carcinoma (Cell Line: NCI-H460)	[4]
Letrozole + Busulfan	DCCBWRL	Letrozole	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[4]
Letrozole + Busulfan	DCW8A0O	Letrozole	Malignant melanoma (Cell Line: LOX IMVI)	[4]
Letrozole + Busulfan	DCDGV8Q	Letrozole	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[4]
Levamisole + Busulfan	DCA2053	Levamisole	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
LIAROZOLE + Busulfan	DC9ZNZ4	LIAROZOLE	Anaplastic large cell lymphoma (Cell Line: SR)	[4]
LIAROZOLE + Busulfan	DC9COTM	LIAROZOLE	Astrocytoma (Cell Line: U251)	[4]
LIAROZOLE + Busulfan	DC0NOCQ	LIAROZOLE	Adenocarcinoma (Cell Line: OVCAR3)	[3]
LIAROZOLE + Busulfan	DCUXG01	LIAROZOLE	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[3]
Mechlorethamine + Busulfan	DCMUQV7	Mechlorethamine	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[4]
Mechlorethamine + Busulfan	DCCH36P	Mechlorethamine	Cutaneous melanoma (Cell Line: SK-MEL-28)	[3]
Mechlorethamine + Busulfan	DCHPNYE	Mechlorethamine	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)	[3]
Mefloquine + Busulfan	DC1IRCH	Mefloquine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Mepacrine + Busulfan	DCRXWJX	Mepacrine	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[4]
Mepacrine + Busulfan	DCNP7TG	Mepacrine	Colon carcinoma (Cell Line: KM12)	[5]
Mepacrine + Busulfan	DC1702T	Mepacrine	Invasive ductal carcinoma (Cell Line: T-47D)	[5]
Mepacrine + Busulfan	DCS6ZHR	Mepacrine	Malignant melanoma (Cell Line: LOX IMVI)	[3]
Mercaptopurine + Busulfan	DCDMS5W	Mercaptopurine	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[4]
Mercaptopurine + Busulfan	DCTVBKH	Mercaptopurine	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[4]
Mercaptopurine + Busulfan	DCRAEMU	Mercaptopurine	Glioma (Cell Line: SF-539)	[4]
Methotrexate + Busulfan	DCJZ0MU	Methotrexate	Anaplastic large cell lymphoma (Cell Line: SR)	[4]
Naltrexone + Busulfan	DCTTWEB	Naltrexone	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Naringenin + Busulfan	DCIDEUI	Naringenin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Nilotinib + Busulfan	DCGB4BB	Nilotinib	Astrocytoma (Cell Line: SNB-19)	[4]
Nilotinib + Busulfan	DCE3PJK	Nilotinib	Glioma (Cell Line: SF-539)	[4]
Nilotinib + Busulfan	DC0KFHQ	Nilotinib	Adenocarcinoma (Cell Line: DU-145)	[3]
Nilotinib + Busulfan	DCCURTI	Nilotinib	Adenocarcinoma (Cell Line: NCIH23)	[3]
Nilotinib + Busulfan	DCX423W	Nilotinib	Adenocarcinoma (Cell Line: HCT116)	[3]
Nilotinib + Busulfan	DCLO7M2	Nilotinib	Amelanotic melanoma (Cell Line: M14)	[3]
Nilotinib + Busulfan	DC7VEX6	Nilotinib	Cutaneous melanoma (Cell Line: SK-MEL-28)	[3]
Nilotinib + Busulfan	DCNWSHD	Nilotinib	Malignant melanoma (Cell Line: LOX IMVI)	[3]
Nilotinib + Busulfan	DCRTSJ3	Nilotinib	Prostate carcinoma (Cell Line: PC-3)	[3]
Norcisapride + Busulfan	DCIF4WD	Norcisapride	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Olmesartan medoxomil + Busulfan	DCL8QBJ	Olmesartan medoxomil	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Oseltamivir + Busulfan	DCK4JAP	Oseltamivir	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Pazopanib HCl + Busulfan	DCYNRSG	Pazopanib HCl	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Picoplatin + Busulfan	DC69D64	Picoplatin	Amelanotic melanoma (Cell Line: M14)	[3]
Picoplatin + Busulfan	DC00P7P	Picoplatin	Cutaneous melanoma (Cell Line: SK-MEL-28)	[3]
Picoplatin + Busulfan	DCYVD5V	Picoplatin	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[3]
Picoplatin + Busulfan	DCXXZBO	Picoplatin	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[3]
Picoplatin + Busulfan	DC7NCXD	Picoplatin	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Plicamycin + Busulfan	DCFFY0F	Plicamycin	Chronic myelogenous leukemia (Cell Line: K-562)	[4]
Plicamycin + Busulfan	DCIB3Z3	Plicamycin	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[4]
Plicamycin + Busulfan	DCXVJIA	Plicamycin	Glioma (Cell Line: SF-539)	[4]
Plicamycin + Busulfan	DCUX9QA	Plicamycin	Renal cell carcinoma (Cell Line: UO-31)	[4]
Plicamycin + Busulfan	DCLEK33	Plicamycin	Invasive ductal carcinoma (Cell Line: T-47D)	[5]
Plicamycin + Busulfan	DC6NUZ8	Plicamycin	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Pralatrexate + Busulfan	DCI4N53	Pralatrexate	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[4]
Pralatrexate + Busulfan	DC1D1SU	Pralatrexate	Adenocarcinoma (Cell Line: NCIH23)	[3]
Pralatrexate + Busulfan	DCZKWGA	Pralatrexate	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)	[3]
Quinine + Busulfan	DCN7T40	Quinine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Raloxifene + Busulfan	DCFW3Q4	Raloxifene	Astrocytoma (Cell Line: SNB-19)	[4]
Raloxifene + Busulfan	DC0GBW1	Raloxifene	Clear cell renal cell carcinoma (Cell Line: TK-10)	[4]
Raloxifene + Busulfan	DCZZYVX	Raloxifene	Glioma (Cell Line: SF-268)	[4]
Raloxifene + Busulfan	DCHBCJZ	Raloxifene	Prostate carcinoma (Cell Line: PC-3)	[3]
Ribavirin-TP + Busulfan	DCD7GWU	Ribavirin-TP	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Romidepsin + Busulfan	DCCN4KA	Romidepsin	Adenocarcinoma (Cell Line: HCT-15)	[3]
Ruxolitinib + Busulfan	DCM2PIN	Ruxolitinib	Adenocarcinoma (Cell Line: HCC-2998)	[3]
SCH 727965 + Busulfan	DCOHUCK	SCH 727965	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)	[3]
Sirolimus + Busulfan	DCVQGER	Sirolimus	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)	[3]
Sirolimus + Busulfan	DCVAPHW	Sirolimus	Non-small cell lung carcinoma (Cell Line: HOP-92)	[3]
SY-1425 + Busulfan	DC65S4M	SY-1425	Astrocytoma (Cell Line: U251)	[4]
SY-1425 + Busulfan	DCG5IXA	SY-1425	Glioblastoma (Cell Line: SNB-75)	[4]
SY-1425 + Busulfan	DC9NX6I	SY-1425	Adenocarcinoma (Cell Line: OVCAR3)	[3]
SY-1425 + Busulfan	DCDZJPP	SY-1425	Amelanotic melanoma (Cell Line: M14)	[3]
SY-1425 + Busulfan	DCPKWER	SY-1425	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[3]
TEM + Busulfan	DCMT7OV	TEM	Adenocarcinoma (Cell Line: OVCAR3)	[3]
TEM + Busulfan	DCDVIRC	TEM	Adenocarcinoma (Cell Line: HT29)	[3]
TEM + Busulfan	DCTWY31	TEM	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)	[3]
Terameprocol + Busulfan	DCGJO43	Terameprocol	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[4]
Terameprocol + Busulfan	DC7X2NV	Terameprocol	Astrocytoma (Cell Line: U251)	[4]
Terameprocol + Busulfan	DCZ5T9J	Terameprocol	Colon carcinoma (Cell Line: KM12)	[5]
Terameprocol + Busulfan	DCJ3BJY	Terameprocol	Invasive ductal carcinoma (Cell Line: BT-549)	[5]
Terameprocol + Busulfan	DC779ZC	Terameprocol	Adenocarcinoma (Cell Line: DU-145)	[3]
Terameprocol + Busulfan	DC6F020	Terameprocol	Cutaneous melanoma (Cell Line: SK-MEL-5)	[3]
Terameprocol + Busulfan	DC8XGP3	Terameprocol	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[3]
Terameprocol + Busulfan	DCPSS7J	Terameprocol	Lung adenocarcinoma (Cell Line: HOP-62)	[3]
Thioguanine + Busulfan	DCLW6ZP	Thioguanine	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[4]
Thioguanine + Busulfan	DCH4K6P	Thioguanine	Anaplastic large cell lymphoma (Cell Line: SR)	[4]
Thioguanine + Busulfan	DC0F938	Thioguanine	Glioma (Cell Line: SF-539)	[4]
Thioguanine + Busulfan	DCIL8G1	Thioguanine	Glioma (Cell Line: SF-268)	[4]
Thioguanine + Busulfan	DCBU08O	Thioguanine	Renal cell carcinoma (Cell Line: SN12C)	[4]
Thioguanine + Busulfan	DCAV18O	Thioguanine	Adenocarcinoma (Cell Line: NCIH23)	[3]
Thioguanine + Busulfan	DCQVAJG	Thioguanine	Adenocarcinoma (Cell Line: SW-620)	[3]
Thioguanine + Busulfan	DC77SEC	Thioguanine	Adenocarcinoma (Cell Line: HCT116)	[3]
Thioguanine + Busulfan	DCRK05Z	Thioguanine	Large cell lung carcinoma (Cell Line: NCI-H460)	[3]
Thioguanine + Busulfan	DCCL7UT	Thioguanine	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Tiagabine + Busulfan	DC094FA	Tiagabine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
Topotecan + Busulfan	DCL5141	Topotecan	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[3]
Topotecan + Busulfan	DC5PCH6	Topotecan	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Topotecan + Busulfan	DCFXNOM	Topotecan	Clear cell renal cell carcinoma (Cell Line: TK-10)	[3]
Topotecan + Busulfan	DCHL8UJ	Topotecan	Clear cell renal cell carcinoma (Cell Line: 786-0)	[3]
Topotecan + Busulfan	DCVB16S	Topotecan	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[3]
Topotecan + Busulfan	DC8I515	Topotecan	Glioma (Cell Line: SF-268)	[3]
Topotecan + Busulfan	DC9H4E9	Topotecan	Melanoma (Cell Line: MALME-3M)	[3]
Topotecan + Busulfan	DC2P3HY	Topotecan	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Topotecan + Busulfan	DCOBW8T	Topotecan	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[3]
Triapine + Busulfan	DC0128H	Triapine	Invasive ductal carcinoma (Cell Line: T-47D)	[5]
Triapine + Busulfan	DC29J1S	Triapine	Adenocarcinoma (Cell Line: HCT-15)	[3]
Triapine + Busulfan	DCT8OP2	Triapine	Astrocytoma (Cell Line: U251)	[3]
Triapine + Busulfan	DCPPO5A	Triapine	Glioma (Cell Line: SF-539)	[3]
Triapine + Busulfan	DC0VNWG	Triapine	Glioma (Cell Line: SF-268)	[3]
Triapine + Busulfan	DC1E2Q6	Triapine	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[3]
Triapine + Busulfan	DCW0OZI	Triapine	Lung adenocarcinoma (Cell Line: HOP-62)	[3]
Trifluridine + Busulfan	DCTUQAX	Trifluridine	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[4]
Trifluridine + Busulfan	DCTUEWS	Trifluridine	Plasma cell myeloma (Cell Line: RPMI-8226)	[4]
Trifluridine + Busulfan	DC81FC0	Trifluridine	Invasive ductal carcinoma (Cell Line: T-47D)	[5]
Trifluridine + Busulfan	DCQB2JN	Trifluridine	Lung adenocarcinoma (Cell Line: EKVX)	[3]
Uracil mustard + Busulfan	DC3SHRL	Uracil mustard	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[4]
Uracil mustard + Busulfan	DCYXYP5	Uracil mustard	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[4]
Uracil mustard + Busulfan	DCUF607	Uracil mustard	Anaplastic large cell lymphoma (Cell Line: SR)	[4]
Uracil mustard + Busulfan	DCDNVUW	Uracil mustard	Plasma cell myeloma (Cell Line: RPMI-8226)	[4]
Uracil mustard + Busulfan	DC12MFM	Uracil mustard	Colon adenocarcinoma (Cell Line: COLO 205)	[5]
Uracil mustard + Busulfan	DCPR6CS	Uracil mustard	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[3]
Valrubicin + Busulfan	DC8WJGM	Valrubicin	Adenocarcinoma (Cell Line: HCT-15)	[3]
Vandetanib + Busulfan	DCFLYLZ	Vandetanib	Anaplastic large cell lymphoma (Cell Line: SR)	[3]
Vemurafenib + Busulfan	DC67E76	Vemurafenib	Adenocarcinoma (Cell Line: DU-145)	[3]
Vemurafenib + Busulfan	DCIXRZ4	Vemurafenib	Malignant melanoma (Cell Line: LOX IMVI)	[3]
Vemurafenib + Busulfan	DCLYQ4F	Vemurafenib	Melanoma (Cell Line: SK-MEL-2)	[3]
Vincristine + Busulfan	DC3OSUX	Vincristine	Adenocarcinoma (Cell Line: DU-145)	[4]
Vincristine + Busulfan	DC3JP64	Vincristine	Adenocarcinoma (Cell Line: HCC-2998)	[4]
Vincristine + Busulfan	DCPG5VL	Vincristine	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[4]
Vincristine + Busulfan	DCCTJCR	Vincristine	Amelanotic melanoma (Cell Line: M14)	[4]
Vincristine + Busulfan	DC43Y43	Vincristine	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[4]
Vincristine + Busulfan	DC0JPIL	Vincristine	Melanoma (Cell Line: UACC-257)	[4]
Vincristine + Busulfan	DCXU1EC	Vincristine	Colon carcinoma (Cell Line: KM12)	[5]
Vinflunine + Busulfan	DC2NGHB	Vinflunine	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[4]
Vinflunine + Busulfan	DCFSTQT	Vinflunine	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[4]
Vinflunine + Busulfan	DC6N1J7	Vinflunine	Astrocytoma (Cell Line: U251)	[4]
Vinflunine + Busulfan	DC6S3KI	Vinflunine	Glioblastoma (Cell Line: SNB-75)	[4]
Vinflunine + Busulfan	DCPJBD0	Vinflunine	Renal cell carcinoma (Cell Line: UO-31)	[4]
Vinflunine + Busulfan	DC2718J	Vinflunine	Carcinoma (Cell Line: MCF7)	[5]
Vinflunine + Busulfan	DC4M7MG	Vinflunine	Colon carcinoma (Cell Line: KM12)	[5]
Vinflunine + Busulfan	DCR558C	Vinflunine	Adenocarcinoma (Cell Line: DU-145)	[3]
Vinflunine + Busulfan	DC7VHPF	Vinflunine	Adenocarcinoma (Cell Line: HT29)	[3]
Vinflunine + Busulfan	DCR0R5F	Vinflunine	Malignant melanoma (Cell Line: UACC62)	[3]
WAY-100635 + Busulfan	DC1JVKW	WAY-100635	Chronic myelogenous leukemia (Cell Line: KBM-7)	[4]
------------------------------------------------------------------------------------


⏷ Show the Full List of 383 DrugCom(s)

8 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Bortezomib + Busulfan	DCTBJYN	Bortezomib	Multiple Myeloma	[6]
Clofarabine + Busulfan	DCVVZTZ	Clofarabine	Acute Myeloid Leukemia	[7]
Cyclophosphamide + Busulfan	DC2N014	Cyclophosphamide	Leukemia, Myeloid, Chronic	[8]
Cyclophosphamide + Busulfan	DCUCBNI	Cyclophosphamide	Leukemia	[9]
Etoposide + Busulfan	DC0OXFQ	Etoposide	Adult Acute Basophilic Leukemia	[10]
Etoposide + Busulfan	DCPI550	Etoposide	Adult Acute Myeloid Leukemia in Remission	[11]
Fludarabine + Busulfan	DCMXG0T	Fludarabine	Diamond-Blackfan Anemia	[12]
Cladribine + Busulfan	DCRF4SL	Cladribine	High Risk Acute Myeloid Leukemia	[13]
------------------------------------------------------------------------------------


⏷ Show the Full List of 8 DrugCom(s)

References

1	Busulfan FDA Label
2	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7136).
3	Loss of function mutations in VARS encoding cytoplasmic valyl-tRNA synthetase cause microcephaly, seizures, and progressive cerebral atrophy.Hum Genet. 2018 Apr;137(4):293-303. doi: 10.1007/s00439-018-1882-3. Epub 2018 Apr 24.
4	Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
5	Biologically active neutrophil chemokine pattern in tonsillitis.Clin Exp Immunol. 2004 Mar;135(3):511-8. doi: 10.1111/j.1365-2249.2003.02390.x.
6	ClinicalTrials.gov (NCT01009840) IV Busulfan Plus Bortezomib Conditioning Regimen for Second Autologous Stem Cell Transplant in Multiple Myeloma Patients
7	ClinicalTrials.gov (NCT01643668) Busulfan/Clofarabine + Allogeneic Stem Cell Transplantation
8	ClinicalTrials.gov (NCT00176930) Stem Cell Transplant for Hematological Malignancy
9	ClinicalTrials.gov (NCT00054327) Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
10	ClinicalTrials.gov (NCT00006363) Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia
11	ClinicalTrials.gov (NCT00003875) Busulfan and Etoposide Followed by Peripheral Blood Stem Cell Transplant and Low-Dose Aldesleukin in Treating Patients With Acute Myeloid Leukemia
12	ClinicalTrials.gov (NCT00176878) Stem Cell Transplant for Bone Marrow Failure Syndromes
13	ClinicalTrials.gov (NCT03384212) CBA Versus FBA Conditioning Followed by Allogeneic HSCT in Treatment of High Risk and Refractory AML